Evidence map›Paper›PMID 33257445›Full record

ArticleAntimicrobial agents and chemotherapy2021

Whole-Genome and Targeted-Amplicon Sequencing of Fluconazole-Susceptible and -Resistant Candida parapsilosis Isolates from Kuwait Reveals a Previously Undescribed N1132D Polymorphism in

Mohammad Asadzadeh, Mohammed Dashti, Suhail Ahmad, Wadha Alfouzan, Abbas Alameer

Open access · greenAbstract readLetter
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Evolution of Fluconazole Resistance Mechanisms and Clonal Types ofAntimicrobial agents and chemotherapy · 2022
    Article
  8. Article
  9. Nationwide Surveillance of Antifungal Resistance ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  10. Fluconazole-resistantFrontiers in fungal biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohammad AsadzadehDepartment of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
Mohammed DashtiGenetics and Bioinformatics Department, Dasman Diabetes Institute, Kuwait City, Kuwait.
Suhail AhmadDepartment of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait suhail.ahmad@ku.edu.kw.ORCID 0000-0003-3492-4781
Wadha AlfouzanDepartment of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
Abbas AlameerDepartment of Biological Science, Faculty of Science, Kuwait University, Khaldiya, Kuwait.
Kuwait University · KWDasman Diabetes Institute · KW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Candida parapsilosisFluconazoleAntifungal AgentsCandidaDrug Resistance, FungalKuwaitMicrobial Sensitivity TestsAntifungal AgentsFluconazoleCandida parapsilosisCDR1fluconazole resistanceN1132D polymorphismwhole-genome sequencing

Identifiers

PMID33257445
PMCPMC7848974
OpenAlexW3108701432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.